Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
The NDA for New Indication of Henlius Anti-PD-1 mAb Serplulimab in Combination with Chemotherapy for the First-line Treatment of non-squamous NSCLC Accepted by the NMPA 2023-12-12 20:30
KOSMODE HEALTH SINGAPORE PTE LTD, CLINCHES "THE MOST TRANSFORMATIONAL COLLABORATION" 2023 SICC AWARDS IN PARTNERSHIP WITH NESTLÉ SINGAPORE AND NESTLÉ R&D CENTRE. 2023-12-12 20:00
Dizal Impresses with Its Differentiated Hematological Oncology Portfolio at 2023 ASH 2023-12-12 18:00
Dr. Eliza Fok, Chairman of the Hong Kong Breast Cancer Foundation Is Honoured with "Women of Power 2023" by Prestige Hong Kong 2023-12-12 17:58
Illumina partners with HaploX to build a domestically produced flagship benchtop sequencing system 2023-12-12 17:31
WuXi Biologics Named to 2023 Dow Jones Sustainability World Index 2023-12-12 17:00
ICP DAS - BMP's Medical-Grade TPU Takes Center Stage at Top Global Medical & Plastic Exhibitions 2023-12-12 16:51
Musim Mas Launched Women Smallholders Training Program 2023-12-12 16:00
Fertility Journey with Femometer Ring: Where Style Meets Precision in Ovulation Tracking 2023-12-12 14:26
MGI Wraps Up Inaugural the Future of Omics Research Summit 2023-12-12 11:09
Qilu Pharmaceutical Announces Results from Phase I Clinical Study for Its Novel Bispecific Antibody QLS31905 at ESMO Immuno-Oncology Congress 2023-12-12 11:04
Live from ASH 2023 | Ascentage Pharma Presents the First Dataset of Bcl-2 inhibitor Lisaftoclax in Patients with AML, Demonstrating Favorable Efficacy and Safety 2023-12-12 09:41
IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023 2023-12-12 03:30
Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium 2023-12-12 00:42
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project 2023-12-11 22:30
Inovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® Platform 2023-12-11 22:00
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments 2023-12-11 21:00
Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting 2023-12-11 21:00
HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors 2023-12-11 20:00
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial 2023-12-11 20:00
1 149 150 151 152 153 1619